2026 NPPES data Hematology & Oncology Physician NPI 1649256066 MD
Verify on CMS →

BRUCE WALLACH, MD

Hematology & Oncology Physician in EDISON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
734
Medicare Part D claims · 117 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$95.53
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BRUCE WALLACH, MD reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 734 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
734
Part D claims, 2023
55%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BRUCE WALLACH, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BRUCE WALLACH, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BRUCE WALLACH, MD?

High performer (top quartile)

NPI registry status

Active

Issued 12/17/2005

NPI 1649256066

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

734 13% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Hematology & Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Hematology & Oncology Physician share within New Jersey

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New Jersey

Medicare quality performance — MIPS

BRUCE WALLACH, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Hematology & Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BRUCE WALLACH, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 34-36 PROGRESS ST., EDISON, NJ, 08820, with a listed phone of (908) 757-9696. NPI 1649256066 was issued on 12/17/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WALLACH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 734 prescription claims written by this provider, covering 117 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 45% brand-name and 55% generic by claim count, with an opioid prescribing rate of 5.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

34-36 PROGRESS ST.
EDISON, NJ 08820

Provider Details

NPI 1649256066
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 12/17/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BRUCE WALLACH, MD. Source: openpaymentsdata.cms.gov.

Total received

$96

Largest payer

Gilead Sciences, Inc.

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

BRUCE WALLACH, MD — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 734 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

734
Total Claims
$1.9M
Total Drug Cost
117
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
969
Total Day Supply
26,862
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$1.9M
Generic Drug Cost
$38K
Opioid Claims
40 (5.4% rate)

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
2.21
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BRUCE WALLACH, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
87
Eliquis
Apixaban
71
Hydroxyurea
63
Procrit
Epoetin Alfa
53
Aranesp
Darbepoetin Alfa In Polysorbat
47
Tamoxifen Citrate
36
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
26
Acyclovir
24
Darzalex Faspro
Daratumumab-Hyaluronidase-Fihj
22
Potassium Chloride
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How BRUCE WALLACH, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

BRUCE WALLACH, MD's 734 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as WALLACH.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BRUCE WALLACH, MD's specialty?
BRUCE WALLACH, MD specializes in Hematology & Oncology Physician and practices in EDISON, New Jersey. Credentials: MD.
How much does BRUCE WALLACH, MD prescribe under Medicare Part D?
In 2023, BRUCE WALLACH, MD wrote 734 Medicare Part D claims totaling $1.9M in drug costs for 117 beneficiaries.
What is BRUCE WALLACH, MD's Medicare quality score?
BRUCE WALLACH, MD has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BRUCE WALLACH, MD located?
BRUCE WALLACH, MD is located at 34-36 PROGRESS ST., EDISON, NJ, 08820. Phone: (908) 757-9696.
What is BRUCE WALLACH, MD's NPI number?
BRUCE WALLACH, MD's National Provider Identifier (NPI) is 1649256066, issued on 12/17/2005.
Does BRUCE WALLACH, MD prescribe more brand-name or generic drugs?
BRUCE WALLACH, MD's prescribing is 45% brand-name and 55% generic drugs by claim count, with $1.9M in brand drug costs.
Does BRUCE WALLACH, MD prescribe opioids?
Yes, BRUCE WALLACH, MD had 40 opioid claims in 2023 with an opioid prescribing rate of 5.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does BRUCE WALLACH, MD prescribe most often?
Based on 2023 Medicare Part D data, BRUCE WALLACH, MD's most frequently prescribed drugs include Anastrozole, Eliquis, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BRUCE WALLACH, MD accept Medicare?
BRUCE WALLACH, MD appears in CMS Medicare data with 734 Part D claims and 117 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BRUCE WALLACH, MD's credentials?
BRUCE WALLACH, MD's NPI is 1649256066 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology